RU95121713A - METHOD FOR SIMULTANEOUS PREVENTION OF MENINGOKKKAYA INFECTION, DIPHTERIA, ABDOMIN TYPE, NATURAL Smallpox, INFLUENZA AND VIRAL HEPATITIS - Google Patents

METHOD FOR SIMULTANEOUS PREVENTION OF MENINGOKKKAYA INFECTION, DIPHTERIA, ABDOMIN TYPE, NATURAL Smallpox, INFLUENZA AND VIRAL HEPATITIS

Info

Publication number
RU95121713A
RU95121713A RU95121713/14A RU95121713A RU95121713A RU 95121713 A RU95121713 A RU 95121713A RU 95121713/14 A RU95121713/14 A RU 95121713/14A RU 95121713 A RU95121713 A RU 95121713A RU 95121713 A RU95121713 A RU 95121713A
Authority
RU
Russia
Prior art keywords
influenza
infection
viral hepatitis
meningokkkaya
abdomin
Prior art date
Application number
RU95121713/14A
Other languages
Russian (ru)
Other versions
RU2138287C1 (en
Inventor
А.Ж. Василенко
К.Г. Гапочко
О.П. Мисников
А.П. Савельев
А.В. Степанов
Т.С. Титова
В.А. Харитонова
Original Assignee
Научно-исследовательский институт военной медицины МО РФ
Filing date
Publication date
Application filed by Научно-исследовательский институт военной медицины МО РФ filed Critical Научно-исследовательский институт военной медицины МО РФ
Priority to RU95121713A priority Critical patent/RU2138287C1/en
Priority claimed from RU95121713A external-priority patent/RU2138287C1/en
Publication of RU95121713A publication Critical patent/RU95121713A/en
Application granted granted Critical
Publication of RU2138287C1 publication Critical patent/RU2138287C1/en

Links

Claims (1)

Способ одновременной профилактики менингококковой инфекции, дифтерии, брюшного тифа, натуральной оспы, гриппа и вирусного гепатита, отличающийся тем, что одновременно вводят в организм пять иммунобиологических препаратов по одной человеческой дозе каждого в следующих сочетаниях: смесь менингококковой А-вакцины и дифтерийного анатоксина, смесь живой оспенной и химической сорбированной брюшнотифозной вакцин, инактивированную гриппозную вакцину или нормальный человеческий иммуноглобулин.A method for the simultaneous prevention of meningococcal infection, diphtheria, typhoid fever, smallpox, influenza and viral hepatitis, characterized in that five immunobiological preparations, one human dose of each in the following combinations, are simultaneously introduced into the body: a mixture of meningococcal A-vaccine and diphtheria toxoid, a mixture of live smallpox and chemical sorbed typhoid vaccines, inactivated influenza vaccine or normal human immunoglobulin.
RU95121713A 1995-12-22 1995-12-22 Method of simultaneous prophylaxis of meningococcus infection, diphtheria, abdominal typhoid, natural smallpox, influenza and viral hepatitis RU2138287C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU95121713A RU2138287C1 (en) 1995-12-22 1995-12-22 Method of simultaneous prophylaxis of meningococcus infection, diphtheria, abdominal typhoid, natural smallpox, influenza and viral hepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU95121713A RU2138287C1 (en) 1995-12-22 1995-12-22 Method of simultaneous prophylaxis of meningococcus infection, diphtheria, abdominal typhoid, natural smallpox, influenza and viral hepatitis

Publications (2)

Publication Number Publication Date
RU95121713A true RU95121713A (en) 1998-02-10
RU2138287C1 RU2138287C1 (en) 1999-09-27

Family

ID=20174995

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95121713A RU2138287C1 (en) 1995-12-22 1995-12-22 Method of simultaneous prophylaxis of meningococcus infection, diphtheria, abdominal typhoid, natural smallpox, influenza and viral hepatitis

Country Status (1)

Country Link
RU (1) RU2138287C1 (en)

Similar Documents

Publication Publication Date Title
DK0835133T3 (en) Recombinant smallpox virus rabies and combination preparations and their uses
WO1990006696A3 (en) Meningococcal class 1 outer-membrane protein vaccine
NZ323973A (en) Vaccine compositions for intranasal administration comprising chitosan and use thereof
LU91596I2 (en) Combination of diphtheria toxoid, tetanus toxoid, pertussis antoxin, filamentous hemagglutinin, pertactin, inactivated poliovirus type 1, type 2 and type 3 and capsular polysaccharide of haemophilus influenzae type b (Infanrix - IPV / Hib)
HUP9903169A3 (en) Low pathogenicity prrs live virus vaccines and methods of preparation thereof
NO912825D0 (en) PROCEDURE FOR THE PREPARATION OF COCONJUGATE VACCINES INCLUDING IMMUNOGENIC PROTEIN, HIV RELATED PEPTIDES AND ANIONIC GROUPS.
HK1034460A1 (en) Combination meningitidis b/c vaccines
CA2271008A1 (en) Acellular pertussis vaccine with diphtheria- and tetanus-toxoids
ATE359089T1 (en) PEPTIDES FOR INDURING A CYTOTOXIC T-LYMPHOCYTE RESPONSE DIRECTED AGAINST HEPATITIS B VIRUS
HUP9801266A2 (en) Multimeric, recombinant urease vaccine
CA2115927A1 (en) Peptides for inducing cytotoxic t-lymphocyte responses to hepatitis b virus
CA2216410A1 (en) Improved inactivated vaccines
FR2669346B1 (en) RECOMBINANT POXVIRUS VACCINE AGAINST MEALS.
DE69031351D1 (en) PREPARATIONS AND TREATMENTS OF PNEUMONIA IN ANIMALS
TW340873B (en) Chicken anaemia agent vaccine
AU3313789A (en) Haemophilus influenza type B oxidized polysaccharide-outer membrane protein conjugate vaccine
NZ239281A (en) Antigenic hiv conjugate, vaccine and pharmaceutical composition
Koplan et al. An update on the benefits and costs of measles and rubella immunization.
UA27754C2 (en) Combination pediatric vaccine, method of simultaneous combined vaccination
RU95121713A (en) METHOD FOR SIMULTANEOUS PREVENTION OF MENINGOKKKAYA INFECTION, DIPHTERIA, ABDOMIN TYPE, NATURAL Smallpox, INFLUENZA AND VIRAL HEPATITIS
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
Michon et al. Combination conjugate vaccines against multiple serotypes of group B streptococci
ZA881081B (en) Virus antigen,method for its preparation and its use for diagnostic and therapeutic purposes(vaccines)
FR2698271B1 (en) Bovine leukemia virus vaccine, new immunogenic peptide and vaccination kit.
Georgadze et al. Development and testing of antistaphylococcal heterogenous gamma globulin.